Cancer funding
Fort Washington-based National Comprehensive Cancer Network has been awarded a $2.1 million grant.
The grant from Pfizer will help develop a program to study axitinib in tumors, the Business Journal reports. Axitinib could be linked to the growth and metastatic progression of tumors.
WHYY is your source for fact-based, in-depth journalism and information. As a nonprofit organization, we rely on financial support from readers like you. Please give today.